Literature DB >> 15623428

Protein kinase A mediated modulation of acto-myosin kinetics.

Mark Hünlich1, Kelly J Begin, Joseph A Gorga, David E Fishbaugher, Martin M LeWinter, Peter VanBuren.   

Abstract

The effects of protein kinase A (PKA) mediated phosphorylation on thin filament and cross-bridge function is not fully understood. To delineate the effects of troponin I (TnI) phosphorylation by PKA on contractile protein performance, reconstituted thin filaments were treated with PKA. With the use of the in vitro motility assay, PKA treated thin filament function was assessed relative to non-phosphorylated thin filaments in a calcium-regulated system. At maximal calcium activation, unloaded shortening velocity and force did not differ between the groups. However, at submaximal activation, an increase in calcium sensitivity of the thin filament was observed for velocity but a decrease in calcium sensitivity was observed for force. Activation of the thin filament by myosin strong-binding did not elicit a calcium-independent effect. The rightward shift in calcium sensitivity for force and the leftward shift in calcium sensitivity for velocity indicate that PKA phosphorylation of TnI directly modulates the kinetics of the myosin cross-bridge. In addition, the altered velocity dependence on thin filament length implicates reduced myosin cross-bridge binding with PKA treatment. These data highlight the importance of TnI serine 23 and 24 phosphorylation in the modulation of cardiac function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623428     DOI: 10.1016/j.yjmcc.2004.10.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  14 in total

1.  Force-generating capacity of human myosin isoforms extracted from single muscle fibre segments.

Authors:  Meishan Li; Lars Larsson
Journal:  J Physiol       Date:  2010-10-25       Impact factor: 5.182

Review 2.  Functional consequences of sarcomeric protein abnormalities in failing myocardium.

Authors:  Martin M LeWinter
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

3.  Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay.

Authors:  Walid Saber; Kelly J Begin; David M Warshaw; Peter VanBuren
Journal:  J Mol Cell Cardiol       Date:  2008-03-29       Impact factor: 5.000

4.  Protein kinase A changes calcium sensitivity but not crossbridge kinetics in human cardiac myofibrils.

Authors:  John S Walker; Lori A Walker; Ken Margulies; Peter Buttrick; Pieter de Tombe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-15       Impact factor: 4.733

Review 5.  Protein phosphorylation and signal transduction in cardiac thin filaments.

Authors:  R John Solaro; Tomoyoshi Kobayashi
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

6.  Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling.

Authors:  Cameron Donaldson; Bradley M Palmer; Michael Zile; David W Maughan; John S Ikonomidis; Henk Granzier; Markus Meyer; Peter VanBuren; Martin M LeWinter
Journal:  Circ Heart Fail       Date:  2012-09-26       Impact factor: 8.790

7.  Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice.

Authors:  Brandon J Biesiadecki; Kittipong Tachampa; Chao Yuan; Jian-Ping Jin; Pieter P de Tombe; R John Solaro
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

8.  Phosphorylation of cardiac troponin I at protein kinase C site threonine 144 depresses cooperative activation of thin filaments.

Authors:  Qun-Wei Lu; Aaron C Hinken; Stacey E Patrick; R John Solaro; Tomoyoshi Kobayashi
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

9.  Regulation of contraction in mammalian striated muscles--the plot thick-ens.

Authors:  Richard L Moss; Daniel P Fitzsimons
Journal:  J Gen Physiol       Date:  2010-07       Impact factor: 4.086

Review 10.  Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

Authors:  Yuan James Rao; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.